 |
|
Comparison Between Familial and Nonfamilial Melanoma in France
Florent Grange, MD;
Agnès Chompret, MD;
Michel Guilloud-Bataille;
Jean-Claude Guillaume, MD;
Alvaro Margulis, MD;
Michel Prade, MD;
Florence Demenais, MD;
Marie-Françoise Avril, MD
Arch Dermatol. 1995;131(10):1154-1159.
Abstract
| |
Background and Design
Five percent to 10% of cutaneous malignant melanomas (CMMs) occur in a familial setting. Clinical, epidemiologic, and genetic studies of familial CMM in different regions of the world have led to various results. To assess the characteristics of familial CMM in France, the clinical, histologic, and epidemiologic characteristics of 295 patients with CMM were recorded, and a comprehensive familial investigation was performed for each case. Patients with a family history of CMM were compared with nonfamilial cases.
Results
Cutaneous malignant melanoma occurred as a familial cancer in 22 (8%) of 295 patients. Among the multiple variables studied, those significantly associated with the familial occurrence of CMM were red hair, inability to tan, and presence of clinically atypical moles. When these variables were considered together in a mul- tivariate analysis, only the association with red hair (P=.001) and atypical moles (P<.05) remained significant. In addition, the patients with familial melanoma exhibited the following tendencies: a younger age at diagnosis, a higher number of moles, and the development of multiple primary melanomas, but these results did not reach statistical significance. Factors relating to UV light exposure, histologic features of CMM, course of the disease, and occurrence of nonmelanoma cancers showed a similar distribution between familial and nonfamilial
Conclusion
A familial investigation should be performed for each patient with CMM in France, particularly when he or she exhibits phenotypic risk factors for CMM such as red hair and atypical moles.
(Arch Dermatol. 1995;131:1154-1159)
Author Affiliations
From the Departments of Medical Oncology (Drs Grange, Chompret, Guillaume, and Avril), Surgery (Dr Margulis), and Pathology (Dr Prade), Institut Gustave-Roussy, Villejuif, France; and the U 155 (Mr Guilloud-Bataille) and U 358 (Dr Demenais), INSERM Paris, France.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Population-Based Analysis of Prognostic Factors and Survival in Familial Melanoma
Florell et al.
JCO 2005;23:7168-7177.
ABSTRACT
| FULL TEXT
Melanocortin-1 Receptor (MC1R) Gene Variants and Dysplastic Nevi Modify Penetrance of CDKN2A Mutations in French Melanoma-Prone Pedigrees
Chaudru et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:2384-2390.
ABSTRACT
| FULL TEXT
Influence of Genes, Nevi, and Sun Sensitivity on Melanoma Risk in a Family Sample Unselected by Family History and in Melanoma-Prone Families
Chaudru et al.
JNCI J Natl Cancer Inst 2004;96:785-795.
ABSTRACT
| FULL TEXT
c-Kit-Targeting Immunotherapy for Hereditary Melanoma in a Mouse Model
Kato et al.
Cancer Res. 2004;64:801-806.
ABSTRACT
| FULL TEXT
Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure
Briollais et al.
Int J Epidemiol 2000;29:408-415.
ABSTRACT
| FULL TEXT
Multiple Primary Melanoma Is Not a Distinct Biological Entity
Grob
Arch Dermatol 1999;135:325-327.
FULL TEXT
Red Hair as aMarker for Familial Melanoma
Journal Watch Dermatology 1996;1996:4-4.
FULL TEXT
|
